Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122190554 | 12219055 | 4 | F | 20160226 | 20160802 | 20160329 | 20160817 | EXP | US-INSYS THERAPEUTICS, INC-INS201603-000126 | INSYS | 32.07 | YR | M | Y | 0.00000 | 20160817 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122190554 | 12219055 | 1 | PS | SUBSYS | FENTANYL | 1 | Sublingual | 401394A | 202788 | 600 | UG | ||||||||
| 122190554 | 12219055 | 2 | SS | SUBSYS | FENTANYL | 1 | 401394A | 202788 | |||||||||||
| 122190554 | 12219055 | 3 | SS | XANAX | ALPRAZOLAM | 1 | 0 | 1 | MG | ||||||||||
| 122190554 | 12219055 | 4 | SS | Morphine | MORPHINE | 1 | 0 | ||||||||||||
| 122190554 | 12219055 | 5 | SS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 122190554 | 12219055 | 6 | SS | KLONOPIN | CLONAZEPAM | 1 | 0 | ||||||||||||
| 122190554 | 12219055 | 7 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 122190554 | 12219055 | 8 | SS | Marijuana | CANNABIS SATIVA SUBSP. INDICA TOP | 1 | 0 | ||||||||||||
| 122190554 | 12219055 | 9 | SS | DURAGESIC | FENTANYL | 1 | 0 | ||||||||||||
| 122190554 | 12219055 | 10 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 122190554 | 12219055 | 11 | C | KEFLEX | CEPHALEXIN | 1 | 0 | 500 | MG | ||||||||||
| 122190554 | 12219055 | 12 | C | BELSOMRA | SUVOREXANT | 1 | 0 | 10 | MG | ||||||||||
| 122190554 | 12219055 | 13 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | 0 | 50 | MG | ||||||||||
| 122190554 | 12219055 | 14 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122190554 | 12219055 | 1 | Back pain |
| 122190554 | 12219055 | 2 | Back pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122190554 | 12219055 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122190554 | 12219055 | Incorrect route of drug administration | |
| 122190554 | 12219055 | Intentional product misuse | |
| 122190554 | 12219055 | Off label use | |
| 122190554 | 12219055 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |